-
Cell Surface GlycoRNA–RBP Domains Enable Peptide Entry Pathw
2026-05-12
This study reveals that RNA-binding proteins (RBPs) and glycoRNAs cluster on the cell surface, forming specialized nanodomains that regulate cell-penetrating peptide entry. The findings redefine cell surface complexity and highlight new avenues for selectively interrogating protein–RNA assemblies in situ.
-
MK-0812: Optimizing Monocyte Trafficking Inhibitor Protocols
2026-05-12
MK-0812 stands out as a potent, selective CCR2 antagonist, enabling precise disruption of monocyte trafficking in models of inflammation and metabolic dysfunction. This article details actionable workflows, troubleshooting advice, and experimental insights, bridging recent findings on the gut–liver axis with state-of-the-art immunology protocol design.
-
TBXA2R-ERM Signaling Drives Metastatic Spread in TNBC Cells
2026-05-11
This study reveals that the thromboxane A2 receptor (TBXA2R), a GPCR, activates the ERM protein family to drive motility, invasion, and metastatic colonization in triple-negative breast cancer (TNBC) cells. By elucidating a specific signaling axis involving TBXA2R and cytoskeletal regulators, the work identifies new mechanistic targets for anti-metastatic intervention and highlights avenues for future cannabinoid receptor research.
-
Biotin (Vitamin B7) Workflows: Protein Labeling to Motor Ass
2026-05-11
Harness the dual biochemical roles of Biotin (Vitamin B7) for precision protein biotinylation and metabolic pathway analysis. This guide delivers actionable protocol enhancements, troubleshooting strategies, and key insights for leveraging APExBIO’s high-purity biotin in advanced cell transport and enzymatic assays.
-
PP 2 (AG 1879): Precision Src Kinase Inhibition in Research
2026-05-10
PP 2 (AG 1879) delivers nanomolar-selective inhibition of Src family kinases for dissecting cancer, immune, and vascular signaling pathways. This guide covers application-driven workflows, practical troubleshooting, and insight from pivotal vascular studies, empowering researchers with actionable strategies and robust data.
-
LEE011 Succinate: Workflow Optimization with a CDK Inhibitor
2026-05-09
Unlock the full potential of LEE011 succinate in advanced cancer research workflows. This guide delivers practical protocol enhancements, troubleshooting tactics, and comparative insights to ensure robust, reproducible cell cycle and proliferation assays.
-
Technical Guide: Calpain Inhibitor I, ALLN for Apoptosis & I
2026-05-09
Calpain Inhibitor I, ALLN (SKU A2602) is a potent, selective inhibitor targeting calpain and cathepsin proteases, designed for use in apoptosis assays and ischemia-reperfusion injury models. This guide addresses best practices, protocol parameters, and troubleshooting for reliable integration of ALLN into research workflows. It is not intended for diagnostic or therapeutic applications and should be used strictly within controlled laboratory settings.
-
ApoE-Mimetic Peptide COG133: miR-146a Modulation in Diabetic
2026-05-08
The reference study identifies the ApoE-mimetic peptide COG133 as a promising modulator of miR-146a and inflammatory signaling in human diabetic fibroblasts, enhancing wound healing potential while exhibiting antibacterial action. Its mechanistic insights into miRNA regulation and antibacterial activity offer a foundation for new therapeutic interventions in diabetic complications.
-
Peptidisc-Assisted Nanobody Multimerization for Functional P
2026-05-07
Chen and Duong van Hoa introduce a peptidisc-assisted strategy to cluster nanobodies via hydrophobic transmembrane domains, generating multimeric 'polybodies' with enhanced affinity and multispecificity. This approach broadens the protein engineering toolkit by enabling stable, water-soluble assemblies with diverse functional properties.
-
Fluo-4 AM: Precision Fluorescent Calcium Indicator for Live
2026-05-07
Fluo-4 AM from APExBIO is a high-intensity, cell-permeant fluorescent calcium indicator that delivers superior performance for real-time intracellular calcium measurements. Its fast loading kinetics, robust fluorescence, and versatility make it the tool of choice for advanced cell signaling and pharmacological assays, as demonstrated in recent podocyte research.
-
Sulfo-NHS-SS-Biotin: Reliable Cell Surface Protein Labeling
2026-05-06
Discover how Sulfo-NHS-SS-Biotin (SKU A8005) addresses core challenges in cell surface protein labeling and affinity purification workflows. This scenario-driven article provides protocol optimization, data-backed recommendations, and vendor selection guidance—empowering biomedical researchers to achieve reproducible, high-fidelity results using APExBIO’s trusted biotin disulfide N-hydroxysuccinimide ester.
-
Vascular Responsiveness in Septic Shock: Insights from VNERi
2026-05-06
Goury et al. introduce a novel index, VNERi, adjusting diastolic arterial pressure for both heart rate and norepinephrine dose, to better characterize vascular responsiveness in early septic shock. Their findings suggest VNERi outperforms traditional hemodynamic markers in predicting patient outcomes, with implications for clinical decision-making and translational research.
-
Native PAGE Kit (PI ≤ 7.0): Preserving Native Protein Struct
2026-05-05
The Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit enables high-resolution native protein gel electrophoresis for acidic proteins. This kit, from APExBIO, maintains protein conformation and activity by avoiding denaturing agents, supporting workflows in protein purification and identification.
-
Intestinal TM6SF2 Safeguards Against Steatohepatitis via Gut
2026-05-05
This reference study elucidates the crucial protective function of intestinal TM6SF2 against the development of metabolic dysfunction-associated steatohepatitis (MASH) in mice. Mechanistically, TM6SF2 deficiency in intestinal epithelial cells disrupts barrier integrity and gut microbiota, leading to hepatic lipid accumulation and inflammation via lysophosphatidic acid (LPA), highlighting new intervention targets for MASH.
-
Auranofin: Thioredoxin Reductase Inhibitor in Oncology Workf
2026-05-04
Auranofin stands out as a precision thioredoxin reductase inhibitor, driving redox disruption and apoptosis in cancer and infectious disease models. This article translates cutting-edge metabolic research and practical workflow guidance into actionable protocols for cancer researchers seeking robust, reproducible results.